← Evidence map

ArticleFrontiers in pharmacology2024

Blestriarene C exerts an inhibitory effect on triple-negative breast cancer through multiple signaling pathways.

Junsha An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39502536